Belgian Blue cattle are known for their high degree of muscling and good carcass qualities. This high degree of muscling is mainly caused by a mutation in the myostatin gene (MSTN). Although the MSTN mutation is considered as fixed in the Belgian Blue breed, segregation is occurring in a sub-population bred for dual purpose. In the latter population, we observed an association between the mutation in MSTN and susceptibility to psoroptic mange, a skin disease caused by Psoroptes ovis mites that heavily plagues Belgian Blue cattle. In total, 291 animals were sampled and screened for their susceptibility for mange lesions and their MSTN genotype. Via linear mixed modelling, we observed that homozygous mutant animals had a significant increase in the size of mange lesions (+2.51% lesion extent) compared to homozygous wild type. These findings were confirmed with zero-inflated modelling, an animal model and odds analysis. Risk ratios for developing severe mange lesions were 5.9 times as high for homozygous mutant animals. All analyses confirmed an association between the MSTN genotype and psoroptic mange lesion size.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.animal.2022.100460 | DOI Listing |
Animal
December 2024
Institute of Animal Breeding and Husbandry, Christian-Albrechts-University Kiel, Hermann-Rodewald-Straße 6, 24118 Kiel, Germany.
Producing calves with higher economic value by utilising semen from beef breeds in dairy herds (Beef-on-Dairy, BoD) has become more common in recent times. Such crossbreed calves promise better carcass conformation and higher consumer acceptance due to the better flavour, but the widespread adaptation of BoD requires careful consideration of the sire breed to maximise the benefits. In this regard, two major traits of interest are calving difficulty and gestation length due to associated costs.
View Article and Find Full Text PDFLancet Oncol
November 2024
Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Lancet Oncol
November 2024
Institute of Neuroscience and Medicine (INM-4), Research Center Juelich (FZJ), Juelich, Germany; Department of Neurology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
The development, application, and benchmarking of artificial intelligence (AI) tools to improve diagnosis, prognostication, and therapy in neuro-oncology are increasing at a rapid pace. This Policy Review provides an overview and critical assessment of the work to date in this field, focusing on diagnostic AI models of key genomic markers, predictive AI models of response before and after therapy, and differentiation of true disease progression from treatment-related changes, which is a considerable challenge based on current clinical care in neuro-oncology. Furthermore, promising future directions, including the use of AI for automated response assessment in neuro-oncology, are discussed.
View Article and Find Full Text PDFEnviron Sci Pollut Res Int
November 2024
Flanders Marine Institute (VLIZ), InnovOcean Campus, Jacobsenstraat 1, 8400, Ostend, Belgium.
Asian Bioeth Rev
October 2024
Unit of Ethics and Human-Animal Studies, Messerli Research Institute, University of Veterinary Medicine Vienna, Medical University of Vienna, University of Vienna, Vienna, Austria.
When it comes to invasive manipulation of animals on the biological level, reactions of disgust are common and often influential on people's moral judgments. As a case in point, the Belgian Blue, a breed of hyper-enhanced cattle which will serve as a case study for the present article, has historically been met with revulsion. Traditionally, in bio- and animal ethics, this 'yuck factor,' has been denied any productive role in proper moral justification, since rationalism is still a dominant paradigm in those disciplines.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!